Calvin C. Sheng
About
In The Last Decade
Calvin C. Sheng
16 papers receiving 886 citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Molecular Biology 524
- Cardiology and Cardiovascular Medicine 323
- Surgery 267
- Biomedical Engineering 217
- Biomaterials 100
Countries citing papers authored by Calvin C. Sheng
This map shows the geographic impact of Calvin C. Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calvin C. Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calvin C. Sheng more than expected).
Fields of papers citing papers by Calvin C. Sheng
This network shows the impact of papers produced by Calvin C. Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calvin C. Sheng. The network helps show where Calvin C. Sheng may publish in the future.
Co-authorship network of co-authors of Calvin C. Sheng
This figure shows the co-authorship network connecting the top 25 collaborators of Calvin C. Sheng. A scholar is included among the top collaborators of Calvin C. Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Calvin C. Sheng. Calvin C. Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 17 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | Canakinumab to Reduce Deterioration of Cardiac and Respiratory Function in Sars-cov2 Associated Myocardial Injury With Heightened Inflammation (canakinumab in Covid-19 Cardiac Injury): Results From the Randomized Three C Study | 1 |
| 7 | 41 | |
| 8 | 102 | |
| 9 | 66 | |
| 10 | 33 | |
| 11 | 67 | |
| 12 | 1 | |
| 13 | 0 | |
| 14 | Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy breakdown → | 425 |
| 15 | 2 | |
| 16 | 21 | |
| 17 | 75 | |
| 18 | 37 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.